Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan to Reduce Edema in Newly Diagnosed Glioblastoma
NCT01805453Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in glioblastoma (GBM) comparing Arm A: Losartan with Arm B: Placebo (2 arms). Primary endpoint: Steroid dosage required to control brain edema on the last day of radiotherapy. Started Mar 2013; status: completed.
02
Drugs
losartan
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01805453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01805453.